| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |